1887

Abstract

The complex (Bcc) is a heterogeneous group of bacteria comprising around 20 related species. These bacteria are important opportunistic pathogens, especially in cystic fibrosis (CF) patients, and are associated with a worse prognosis and decreased life expectancy. The taxonomic position of 20 Bcc isolates retrieved from CF patients receiving care at Hospital Santa Maria (HSM), in Lisbon, from 1995 to 2006, was re-examined in the present work. These isolates, formerly classified as (taxon K), are here reclassified as , including the former IST408, which was the focus of previous studies regarding the biosynthesis of the exopolysaccharide ‘cepacian’. The CF population examined has been previously described as having an exceptionally high representation of , presumably due to a contamination arising from saline solutions for nasal application. Twenty-one additional isolates, obtained from a chronically infected patient, from 2006 to 2010, were also identified as . This study also provides insight into the potential clinical impact of , a species that is rarely associated with CF infections. Isolates belonging to this species were shown to be involved in chronic and transient respiratory infections, and were associated with severe lung function deterioration and with a case of death with cepacia syndrome. However, since the patients were co-infected with and other non- bacteria, the role played by is unclear. Nevertheless, isolates were found to prevail over isolates during co-infection of at least one chronically infected patient.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000094
2015-08-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/8/927.html?itemId=/content/journal/jmm/10.1099/jmm.0.000094&mimeType=html&fmt=ahah

References

  1. Agodi A., Barchitta M., Gianninò V., Collura A., Pensabene T., Garlaschi M.L., Pasquarella C., Luzzaro F., Sinatra F., other authors. 2002; Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages. J Hosp Infect 50:188–195 doi:10.1053/jhin.2001.1160 [PubMed] [CrossRef]
    [Google Scholar]
  2. Assaad W., Magalhães M., Plesa M., Hart C.A., Cornelis P., Winstanley C. 2006; Identical Burkholderia cepacia complex strain types isolated from multiple patients attending a hospital in Brazil. J Med Microbiol 55:247–249 doi:10.1099/jmm.0.46321-0 [PubMed] [CrossRef]
    [Google Scholar]
  3. Baldwin A., Mahenthiralingam E., Thickett K.M., Honeybourne D., Maiden M.C., Govan J.R., Speert D.P., Lipuma J.J., Vandamme P., Dowson C.G. 2005; Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 43:4665–4673 doi:10.1128/JCM.43.9.4665-4673.2005 [PubMed] [CrossRef]
    [Google Scholar]
  4. Bernhardt S.A., Spilker T., Coffey T., LiPuma J.J. 2003; Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. Clin Infect Dis 37:780–785 doi:10.1086/377541 [PubMed] [CrossRef]
    [Google Scholar]
  5. Biddick R., Spilker T., Martin A., LiPuma J.J. 2003; Evidence of transmission of Burkholderia cepacia Burkholderia multivorans Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett 228:57–62 doi:10.1016/S0378-1097(03)00724-9 [PubMed] [CrossRef]
    [Google Scholar]
  6. Campana S., Taccetti G., Ravenni N., Favari F., Cariani L., Sciacca A., Savoia D., Collura A., Fiscarelli E., other authors. 2005; Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J Clin Microbiol 43:5136–5142 doi:10.1128/JCM.43.10.5136-5142.2005 [PubMed] [CrossRef]
    [Google Scholar]
  7. Cescutti P., Bosco M., Picotti F., Impallomeni G., Leitão J.H., Richau J.A., Sá-Correia I. 2000; Structural study of the exopolysaccharide produced by a clinical isolate of Burkholderia cepacia . Biochem Biophys Res Commun 273:1088–1094 doi:10.1006/bbrc.2000.3059 [PubMed] [CrossRef]
    [Google Scholar]
  8. Coenye T., Mahenthiralingam E., Henry D., LiPuma J.J., Laevens S., Gillis M., Speert D.P., Vandamme P. 2001; Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol 51:1481–1490[PubMed] [CrossRef]
    [Google Scholar]
  9. Coutinho C.P., de Carvalho C.C.C.R., Madeira A., Pinto-de-Oliveira A., Sá-Correia I. 2011; Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient. Infect Immun 79:2950–2960 doi:10.1128/IAI.01366-10 [PubMed] [CrossRef]
    [Google Scholar]
  10. Cunha M.V., Leitão J.H., Mahenthiralingam E., Vandamme P., Lito L., Barreto C., Salgado M.J., Sá-Correia I. 2003; Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol 41:4113–4120 doi:10.1128/JCM.41.9.4113-4120.2003 [PubMed] [CrossRef]
    [Google Scholar]
  11. Cunha M.V., Sousa S.A., Leitão J.H., Moreira L.M., Videira P.A., Sá-Correia I. 2004; Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol 42:3052–3058 doi:10.1128/JCM.42.7.3052-3058.2004 [PubMed] [CrossRef]
    [Google Scholar]
  12. Cunha M.V., Pinto-de-Oliveira A., Meirinhos-Soares L., Salgado M.J., Melo-Cristino J., Correia S., Barreto C., Sá-Correia I. 2007; Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center. J Clin Microbiol 45:1628–1633 doi:10.1128/JCM.00234-07 [PubMed] [CrossRef]
    [Google Scholar]
  13. Dalmastri C., Pirone L., Tabacchioni S., Bevivino A., Chiarini L. 2005; Efficacy of species-specific recA PCR tests in the identification of Burkholderia cepacia complex environmental isolates. FEMS Microbiol Lett 246:39–45 doi:10.1016/j.femsle.2005.03.041 [PubMed] [CrossRef]
    [Google Scholar]
  14. Dalmastri C., Baldwin A., Tabacchioni S., Bevivino A., Mahenthiralingam E., Chiarini L., Dowson C. 2007; Investigating Burkholderia cepacia complex populations recovered from Italian maize rhizosphere by multilocus sequence typing. Environ Microbiol 9:1632–1639 doi:10.1111/j.1462-2920.2007.01273.x [PubMed] [CrossRef]
    [Google Scholar]
  15. Drevinek P., Mahenthiralingam E. 2010; Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 16:821–830 doi:10.1111/j.1469-0691.2010.03237.x [PubMed] [CrossRef]
    [Google Scholar]
  16. Fang Y., Lou M.-M., Li B., Xie G.-L., Wang F., Zhan L.-X., Luo Y.-C. 2010; Characterization of Burkholderia cepacia complex from cystic fibrosis patients in China and their chitosan susceptibility. World J Microbiol Biotechnol 26:443–450 doi:10.1007/s11274-009-0187-z [CrossRef]
    [Google Scholar]
  17. Ferreira A.S., Silva I.N., Oliveira V.H., Cunha R., Moreira L.M. 2011; Insights into the role of extracellular polysaccharides in Burkholderia adaptation to different environments. Front Cell Infect Microbiol 1:16 doi:10.3389/fcimb.2011.00016 [PubMed] [CrossRef]
    [Google Scholar]
  18. Govan J.R., Brown A.R., Jones A.M. 2007; Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol 2:153–164 doi:10.2217/17460913.2.2.153 [PubMed] [CrossRef]
    [Google Scholar]
  19. Jordá-Vargas L., Degrossi J., Castañeda N.C., D'Aquino M., Valvano M.A., Procopio A., Galanternik L., Centrón D. 2008; Prevalence of indeterminate genetic species of Burkholderia cepacia complex in a cystic fibrosis center in Argentina. J Clin Microbiol 46:1151–1152 doi:10.1128/JCM.01595-07 [PubMed] [CrossRef]
    [Google Scholar]
  20. Kalish L.A., Waltz D.A., Dovey M., Potter-Bynoe G., McAdam A.J., Lipuma J.J., Gerard C., Goldmann D. 2006; Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med 173:421–425 doi:10.1164/rccm.200503-344OC [PubMed] [CrossRef]
    [Google Scholar]
  21. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. 2003; Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2:29–34 doi:10.1016/S1569-1993(02)00141-8 [PubMed] [CrossRef]
    [Google Scholar]
  22. Leite F.C., Machado A.B.M.P., Lutz L., Vieira M.I., Barth A.L. 2011; Molecular identification of Burkholderia cepacia complex and species distribution among cystic fibrosis patients seen at the reference center in southern Brazil. Revista HCPA 31:138–144
    [Google Scholar]
  23. LiPuma J.J. 2005; Update on the Burkholderia cepacia complex. Curr Opin Pulm Med 11:528–533 doi:10.1097/01.mcp.0000181475.85187.ed [PubMed] [CrossRef]
    [Google Scholar]
  24. LiPuma J.J. 2010; The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23:299–323 doi:10.1128/CMR.00068-09 [PubMed] [CrossRef]
    [Google Scholar]
  25. LiPuma J.J., Spilker T., Gill L.H., Campbell P.W. III, Liu L., Mahenthiralingam E. 2001; Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 164:92–96 doi:10.1164/ajrccm.164.1.2011153 [PubMed] [CrossRef]
    [Google Scholar]
  26. Magalhães M., Doherty C., Govan J.R., Vandamme P. 2003; Polyclonal outbreak of Burkholderia cepacia complex bacteraemia in haemodialysis patients. J Hosp Infect 54:120–123 doi:10.1016/S0195-6701(03)00118-X [PubMed] [CrossRef]
    [Google Scholar]
  27. Mahenthiralingam E., Vandamme P. 2005; Taxonomy and pathogenesis of the Burkholderia cepacia complex. Chron Respir Dis 2:209–217 doi:10.1191/1479972305cd053ra [PubMed] [CrossRef]
    [Google Scholar]
  28. Mahenthiralingam E., Bischof J., Byrne S.K., Radomski C., Davies J.E., Av-Gay Y., Vandamme P. 2000; DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis Burkholderia multivorans Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38:3165–3173[PubMed]
    [Google Scholar]
  29. Mahenthiralingam E., Baldwin A., Vandamme P. 2002; Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol 51:533–538[PubMed] [CrossRef]
    [Google Scholar]
  30. Mahenthiralingam E., Baldwin A., Drevinek P., Vanlaere E., Vandamme P., LiPuma J.J., Dowson C.G. 2006; Multilocus sequence typing breathes life into a microbial metagenome. PLoS One 1:e17 doi:10.1371/journal.pone.0000017 [PubMed] [CrossRef]
    [Google Scholar]
  31. Mahenthiralingam E., Baldwin A., Dowson C.G. 2008; Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 104:1539–1551 doi:10.1111/j.1365-2672.2007.03706.x [PubMed] [CrossRef]
    [Google Scholar]
  32. Martin M., Christiansen B., Caspari G., Hogardt M., von Thomsen A.J., Ott E., Mattner F. 2011; Hospital-wide outbreak of Burkholderia contaminans caused by prefabricated moist washcloths. J Hosp Infect 77:267–270 doi:10.1016/j.jhin.2010.10.004 [PubMed] [CrossRef]
    [Google Scholar]
  33. Martina P., Bettiol M., Vescina C., Montanaro P., Mannino M.C., Prieto C.I., Vay C., Naumann D., Schmitt J., other authors. 2013; Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina. J Clin Microbiol 51:339–344 doi:10.1128/JCM.02500-12 [PubMed] [CrossRef]
    [Google Scholar]
  34. Medina-Pascual M.J., Valdezate S., Carrasco G., Villalon P., Garrido N., Saez-Nieto J.A. 2015; Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosis. Clin Microbiol Infect 21:150–156 [CrossRef]
    [Google Scholar]
  35. Moreira L.M., Videira P.A., Sousa S.A., Leitão J.H., Cunha M.V., Sá-Correia I. 2003; Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem Biophys Res Commun 312:323–333 doi:10.1016/j.bbrc.2003.10.118 [PubMed] [CrossRef]
    [Google Scholar]
  36. Moreira A.S., Coutinho C.P., Azevedo P., Lito L., Melo-Cristino J., Sá-Correia I. 2014; Burkholderia dolosa phenotypic variation during the decline in lung function of a cystic fibrosis patient during 5.5 years of chronic colonization. J Med Microbiol 63:594–601 doi:10.1099/jmm.0.069849-0 [PubMed] [CrossRef]
    [Google Scholar]
  37. Papaleo M.C., Perrin E., Maida I., Fondi M., Fani R., Vandamme P. 2010; Identification of species of the Burkholderia cepacia complex by sequence analysis of the hisA gene. J Med Microbiol 59:1163–1170 doi:10.1099/jmm.0.019844-0 [PubMed] [CrossRef]
    [Google Scholar]
  38. Payne G.W., Vandamme P., Morgan S.H., Lipuma J.J., Coenye T., Weightman A.J., Jones T.H., Mahenthiralingam E. 2005; Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Environ Microbiol 71:3917–3927 doi:10.1128/AEM.71.7.3917-3927.2005 [PubMed] [CrossRef]
    [Google Scholar]
  39. Peeters C., Zlosnik J.E., Spilker T., Hird T.J., LiPuma J.J., Vandamme P. 2013; Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere. Syst Appl Microbiol 36:483–489 doi:10.1016/j.syapm.2013.06.003 [PubMed] [CrossRef]
    [Google Scholar]
  40. Ramsay K.A., Butler C.A., Paynter S., Ware R.S., Kidd T.J., Wainwright C.E., Bell S.C. 2013; Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. J Clin Microbiol 51:3975–3980 doi:10.1128/JCM.01360-13 [PubMed] [CrossRef]
    [Google Scholar]
  41. Richau J.A., Leitão J.H., Sá-Correia I. 2000; Enzymes leading to the nucleotide sugar precursors for exopolysaccharide synthesis in Burkholderia cepacia . Biochem Biophys Res Commun 276:71–76 doi:10.1006/bbrc.2000.3438 [PubMed] [CrossRef]
    [Google Scholar]
  42. Shehabi A.A., Abu-Al-Soud W., Mahafzah A., Khuri-Bulos N., Abu Khader I., Ouis I.S., Wadström T. 2004; Investigation of Burkholderia cepacia nosocomial outbreak with high fatality in patients suffering from diseases other than cystic fibrosis. Scand J Infect Dis 36:174–178 doi:10.1080/00365540410027166 [PubMed] [CrossRef]
    [Google Scholar]
  43. Sist P., Cescutti P., Skerlavaj S., Urbani R., Leitão J.H., Sá-Correia I., Rizzo R. 2003; Macromolecular and solution properties of Cepacian: the exopolysaccharide produced by a strain of Burkholderia cepacia isolated from a cystic fibrosis patient. Carbohydr Res 338:1861–1867 doi:10.1016/S0008-6215(03)00306-9 [PubMed] [CrossRef]
    [Google Scholar]
  44. Smet B., Mayo M., Peeters C., Zlosnik J.E., Spilker T., Hird T.J., LiPuma J.J., Kidd T.J., Kaestli M., other authors. 2015 doi:10.1099/ijs.0.000251 [Epub ahead of print]. doi:10.1099/ijs.0.000251 Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources. Int J Syst Evol Microbiol
    [Google Scholar]
  45. Souza A.V., Moreira C.R., Pasternak J., Hirata M.L., Saltini D.A., Caetano V.C., Ciosak S., Azevedo F.M., Severino P., other authors. 2004; Characterizing uncommon Burkholderia cepacia complex isolates from an outbreak in a haemodialysis unit. J Med Microbiol 53:999–1005 doi:10.1099/jmm.0.45702-0 [PubMed] [CrossRef]
    [Google Scholar]
  46. Vandamme P., Henry D., Coenye T., Nzula S., Vancanneyt M., LiPuma J.J., Speert D.P., Govan J.R., Mahenthiralingam E. 2002; Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol 33:143–149 doi:10.1111/j.1574-695X.2002.tb00584.x [PubMed] [CrossRef]
    [Google Scholar]
  47. Vanlaere E., Lipuma J.J., Baldwin A., Henry D., De Brandt E., Mahenthiralingam E., Speert D., Dowson C., Vandamme P. 2008; Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol 58:1580–1590 doi:10.1099/ijs.0.65634-0 [PubMed] [CrossRef]
    [Google Scholar]
  48. Vanlaere E., Baldwin A., Gevers D., Henry D., De Brandt E., LiPuma J.J., Mahenthiralingam E., Speert D.P., Dowson C., Vandamme P., Taxon K. 2009; Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 59:102–111 doi:10.1099/ijs.0.001123-0 [PubMed] [CrossRef]
    [Google Scholar]
  49. Vermis K., Coenye T., Mahenthiralingam E., Nelis H.J., Vandamme P. 2002; Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex. J Med Microbiol 51:937–940[PubMed] [CrossRef]
    [Google Scholar]
  50. Vermis K., Coenye T., LiPuma J.J., Mahenthiralingam E., Nelis H.J., Vandamme P. 2004; Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int J Syst Evol Microbiol 54:689–691 doi:10.1099/ijs.0.02888-0 [PubMed] [CrossRef]
    [Google Scholar]
  51. Woods C.W., Bressler A.M., LiPuma J.J., Alexander B.D., Clements D.A., Weber D.J., Moore C.M., Reller L.B., Kaye K.S. 2004; Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia. Clin Infect Dis 38:1243–1250 doi:10.1086/383313 [PubMed] [CrossRef]
    [Google Scholar]
  52. Yabuuchi E., Kawamura Y., Ezaki T., Ikedo M., Dejsirilert S., Fujiwara N., Naka T., Kobayashi K. 2000; Burkholderia uboniae sp. nov., L-arabinose-assimilating but different from Burkholderia thailandensis Burkholderia vietnamiensis . Microbiol Immunol 44:307–317 doi:10.1111/j.1348-0421.2000.tb02500.x [PubMed] [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000094
Loading
/content/journal/jmm/10.1099/jmm.0.000094
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error